MentionFox
Home › Executive changes › Pacific Biosciences Of California, Inc.
Leadership changes · SEC Form 8-K, Item 5.02

Pacific Biosciences Of California, Inc. executive changes

Every leadership change Pacific Biosciences Of California, Inc. reported to the SEC under Item 5.02: who left, who was appointed, to what role and from when, quoted from each filing.

Filings2
Departures named1
Latest filing2026-08-05

Pacific Biosciences Of California, Inc. filed 2 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-08-05. Between them they name 1 person. Each change below is quoted from the filing and linked to it.

Every change, newest first

Filed 2026-08-05 · 8-K

Reported

On July 30, 2026, the Board appointed Mark Van Oene, age 54, as the Company's President and Chief Executive Officer and as a member of the Board, effective August 5, 2026 (the "Effective Date").
Filed 2026-07-09 · 8-K

Departing: Christopher M. Smith, Director

On July 8, 2026, Christopher M. Smith, a member of the board of directors (the "Board") of Pacific Biosciences of California, Inc. (the "Company"), notified the Company of his resignation from the Board, effective immediately.
Hiring for a seat like this?

Find people with the same kind of experience as the Director at Pacific Biosciences Of California, Inc., with the record behind each one.

Find candidates like Director at Pacific Biosciences Of California, Inc.
Selling to Pacific Biosciences Of California, Inc.?

New leaders review vendors and budgets in their first months. Get an alert the next time Pacific Biosciences Of California, Inc. is in the news or changes leadership.

Get an alert when Pacific Biosciences Of California, Inc. changes leadership

Tools for this story

Each opens in a new tab, filled in for Pacific Biosciences Of California, Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/pacific-biosciences-of-california
Last updated 2026-09-27
Primary record: SEC filing 1 · SEC filing 2
Pacific Biosciences Of California, Inc. (PACB) executive changes: 2 leadership filings. MentionFox, 2026-09-27. https://mentionfox.com/executive-changes/pacific-biosciences-of-california